Ara
Toplam kayıt 1, listelenen: 1-1
Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study
(Amer Soc Hematology, 2019)
[No Abstract Available]